CRLF CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. CRLF Gen Silencer sind erhältlich als CRLF CRISPR/Cas9 Knockout Plasmide und CRLF Double Nickase Plasmide. CRLF CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
CRLF CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
CRLF1 CRISPR/Cas9 KO Plasmid (h) | sc-405550 | h | Gene Knockout | GFP | 0 | ||
CRLF1 HDR Plasmid (h) | sc-405550-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CRLF1 Double Nickase Plasmid (h) | sc-405550-NIC | h | Gene Knockout | Puromycin | 0 | ||
CRLF1 Double Nickase Plasmid (h2) | sc-405550-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CRLF1 CRISPR/Cas9 KO Plasmid (m) | sc-419808 | m | Gene Knockout | GFP | 0 | ||
CRLF1 HDR Plasmid (m) | sc-419808-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CRLF1 Double Nickase Plasmid (m) | sc-419808-NIC | m | Gene Knockout | Puromycin | 0 | ||
CRLF1 Double Nickase Plasmid (m2) | sc-419808-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
CRLF3 CRISPR/Cas9 KO Plasmid (h) | sc-407538 | h | Gene Knockout | GFP | 0 | ||
CRLF3 HDR Plasmid (h) | sc-407538-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CRLF3 Double Nickase Plasmid (h) | sc-407538-NIC | h | Gene Knockout | Puromycin | 0 | ||
CRLF3 Double Nickase Plasmid (h2) | sc-407538-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CRLF3 CRISPR/Cas9 KO Plasmid (m) | sc-424857 | m | Gene Knockout | GFP | 0 | ||
CRLF3 HDR Plasmid (m) | sc-424857-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CRLF3 Double Nickase Plasmid (m) | sc-424857-NIC | m | Gene Knockout | Puromycin | 0 | ||
CRLF3 Double Nickase Plasmid (m2) | sc-424857-NIC-2 | m | Gene Knockout | Puromycin | 0 |
CRLF CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
CRLF1 CRISPR Activation Plasmid (h) | sc-405550-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 CRISPR Activation Plasmid (h2) | sc-405550-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (h) | sc-405550-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (h2) | sc-405550-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 CRISPR Activation Plasmid (m) | sc-419808-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 CRISPR Activation Plasmid (m2) | sc-419808-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (m) | sc-419808-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (m2) | sc-419808-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activation Plasmid (h) | sc-407538-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activation Plasmid (h2) | sc-407538-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (h) | sc-407538-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (h2) | sc-407538-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activation Plasmid (m) | sc-424857-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activation Plasmid (m2) | sc-424857-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (m) | sc-424857-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (m2) | sc-424857-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |